Riskpilot← Back to searchSign inGet full accessKuusamon Eläinklinikka Oy
OYActiveY-tunnus 2559063-3Nuottatie 1Veterinary activities · NACE 7500Est. 20133 employees
Revenue 2024
EUR 398K
+8% vs 2023
EBITDA margin
22.2%
+19% vs 2023
Equity ratio
86.1%
Financial strength
Net profit 2024
EUR 44K
-1% vs 2023
| Revenue | EUR 398K | +8% |
| EBITDA | EUR 88K | +19% |
| Net profit | EUR 44K | -1% |
| Total assets | EUR 133K | — |
| Equity | EUR 114K | — |
| Employees | 3 | — |
Legal name
Kuusamon Eläinklinikka Oy
Y-tunnus number
2559063-3
Legal form
Osakeyhtiö
NACE code
7500 · Veterinary activities
Founded
11. heinäkuuta 2013
Share capital
EUR 2 500
Employees
3 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Hallituksen puheenjohtaja ja toimitusjohtaja kumpikin yksin ja hallituksen jäsenet kaksi yhdessä
Company purpose
Yhtiön toimiala on eläinlääkintäpalvelut, niihin liittyvä tavara- ja tarvikemyynti, sekä koulutus- ja asiantuntijapalveluiden myynti. Yhtiö voi toimintaansa varten omistaa ja hallita osakkeita, osuuksia ja kiinteistöjä sekä vuokrata niitä.
Address
Nuottatie 1
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 291 | 324 | 340 | 367 | 398 |
| Staff expenses | −73 | −66 | −70 | −81 | −103 |
| EBITDA | 38 | 73 | 64 | 74 | 88 |
| Depreciation & amort. | −27 | −24 | −31 | −17 | −34 |
| EBIT | 12 | 49 | 32 | 57 | 54 |
| Net financials | −1 | −1 | −1 | −1 | 1 |
| Profit before tax | 11 | 48 | 32 | 56 | 55 |
| Tax | 2 | 10 | 6 | 12 | 11 |
| Net profit | 8 | 38 | 25 | 45 | 44 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 65 | 92 | 87 | 0 | 133 |
| Equity | 13 | 45 | 54 | 0 | 114 |
| Long-term debt | 7 | — | — | 0 | 0 |
| Short-term debt | 45 | 46 | 33 | 0 | 18 |
| Total debt | 52 | 46 | 33 | 0 | 18 |
EBITDA margin
22.2%
This company
15.8%
Market median
+41% vs market
20202024
Equity ratio
86.1%
This company
38.2%
Market median
+125% vs market
20202024
Return on equity
38.5%
This company
18.4%
Market median
+109% vs market
20202024
Net profit margin
11.1%
This company
8.1%
Market median
+37% vs market
20202024
Asset turnover
3.00×
This company
1.12×
Market median
+168% vs market
20202024
Debt / equity
0.16×
This company
0.62×
Market median
+74% vs market
20202024
- Annual report 2024Filed via PRH / YTJ · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via PRH / YTJ · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via PRH / YTJ · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via PRH / YTJ · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via PRH / YTJ · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (4) | ||
MC Deputy auditor | Deputy auditor | 2025 |
AP Chief Executive Officer | Chief Executive Officer | 2014 |
JH | Audit | 2025 |
MK Deputy Member | Deputy Member | 2021 |
| Former (2) | ||
JE Deputy Member | Deputy Member | 2019 – 2020 |
TT Deputy Member | Deputy Member | 2020 – 2021 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Board of Directors | 2019 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Kuusamon Eläinklinikka Oy also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Marko Christian Saxell | Deputy auditor | 0 companies |
| Anna-Maaria Perttuli | Chief Executive Officer | 0 companies |
| Jari Einari Korvala | Deputy Member | 0 companies |
| Joni Henrik Ristevirta | Audit | 0 companies |
| Tarja Tuulikki Kolvanki | Deputy Member | 0 companies |
| Minna Kaisa Marika Nieminen | Deputy Member | 0 companies |
| Heikki Tapani Perttuli | Board of Directors | 0 companies |